Home Products About Us Contact Us Events Press About Apnea Testimonials Dealers
fdgdsf
InnoMed Technologies Receives The 2004 Frost And Sullivan Award For Product Innovation
Date:
04/07/2004 7:45 EST
PALO ALTO, Calif.--(BUSINESS WIRE)--
In a recent study entitled
'Strategic Analysis of World Sleep Apnea Therapeutic Markets,' Frost and
Sullivan recognized InnoMed Technologies Inc.'s revolutionary facial
interface, a product that can provide comfort to millions of people
suffering from sleep apnea, with the 2004 Frost and Sullivan Award for
Product Innovation. Since masks are a very important component of continuous
positive airway pressure (CPAP) therapy for sleep apnea, a comfortable mask
can be crucial for patient compliance. While a number of companies have
focused their efforts on developing better masks, InnoMed Technologies has
excelled with the development of Nasal-Aire, a truly innovative mask. It
does not require any headgear and can be worn like an oxygen canula,
providing highly effective therapy.
'The lack of patient comfort and compliance is one of the biggest reasons
for the failure of CPAP therapy, however, Nasal-Aire offers multiple
benefits to patients including the freedom to speak, sleep in any direction
and wear eyeglasses, which makes it a facial interface of choice,' says
Frost and Sullivan industry analyst Dhiraj Ajmani. For its innovative
product that can help increase patient compliance in the CPAP market,
InnoMed is the recipient of the 2004 Frost and Sullivan Award for Product
Innovation. The award is presented each year to the company that has
demonstrated excellence in new products and technologies within its
industry. The recipient company has shown innovation by launching a broad
line of emerging products and technologies. InnoMed's' product pipeline
includes other novel products such as Nasal PAP Freestyle, a compact and
comfortable interface, and the Nasal-Aire Critical Care device. Frost and
Sullivan expects these products to expand the already growing market for
Nasal-Aire. The company came into existence three years ago and is
ISO1345-1996-certified, and the Nasal-Aire II has received its CE Mark.
InnoMed's products have found good acceptance in over 40 countries. The
research-driven privately owned company is continuously developing
innovative products in the fields of the rapidly growing sleep apnea and
critical care markets. The simple and highly innovative, patient friendly
Nasal-Aire is expected to revolutionize CPAP therapy, driving revenues for
InnoMed Technologies.
About InnoMed Technologies Inc.
InnoMed is a research-oriented, privately held, 21st century medical
technologies company. The company is poised to bring new and more effective
medical products and devices to the public through a medical development and
engineering team, as well as acquisitions of other medical-related
companies. InnoMed holds several patents and has several patents pending.
More information regarding InnoMed Technologies is available at
http://www.innomedinc.com.
About Frost and Sullivan
Founded in 1961, Frost and Sullivan is recognized as a global leader in
growth consulting. Frost and Sullivan Awards are presented to companies that
demonstrate excellence in the industry through diligence, commitment and
innovative business strategies required to advance in the global
marketplace. Frost and Sullivan rigorously analyzes specific criteria to
determine award recipients in a vast variety of market industries and
landscapes. For further information, visit
www.frost.com.
Contact:
Jamie Frizzell
210.247.2496
jfrizzell@frost.com